Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending September 30, 2015. The document serves as a notification of transactions involving Persons Discharging Managerial Responsibilities (PDMRs) and their connected persons, in compliance with DTR 3.1.4R(1)(a) and (c).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to disclosure of specific share transactions and does not contain financial statements or performance metrics.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document solely details the following share transactions:
- Abbas Hussain (PDMR): Sold 152,901 GSK Ordinary Shares at £12.39 per share on September 29, 2015.
- Susan Hussain (Connected Person): Purchased 149,609 GSK Ordinary Shares at £12.54 per share on September 30, 2015.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is a regulatory notification of insider trading activity and contains no strategic commentary.
Investor Verification Points
- Verify the total volume of shares traded by PDMRs and connected persons during the reporting period.
- Confirm the transaction prices (£12.39 and £12.54) against the market price on the respective dates.
- Review the company's annual report (Form 20-F) for comprehensive financial data, as this Form 6-K does not include financial results.